[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fjrvddIulV68U5h3Qdx3Na8Z_gENQT9Bv_xXTjsTWYvQ":8,"$fUUdZw6wHb17cYMbTuipqrcLsKxayTr8IcPyUN9cD98s":55,"$f2TNWs0xdsMFHbT9WkHIaRC15KV4luFUuMCW67QazHZU":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},61713,869663,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//z3LMLrFFFUbfETUQZ6nIXZTq9cw6sehr.png","王利芳","山西省肿瘤医院","内科","主治医师",7,0,"乳腺癌治疗新选择：深入了解紫杉醇脂质体等药物","","https://ystcdn.venuertc.com/venue/AI/faf8b6c2-cc73-4733-a8d8-fc588804ab8b.jpg","\u003C!-- 乳腺癌治疗新选择：深入了解紫杉醇脂质体等药物 | 正确用药实用指南 -->\n\u003Cdiv class=\"material-wrapper\">\n  \u003Ch1 id=\"material_title\" class=\"material-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌治疗新选择：深入了解紫杉醇脂质体等药物\u003C/h1>\n  \u003Cdiv class=\"material-intro\">\n    \u003Cp>说起来，肿瘤化疗药物的发展已经迈进了新的阶段。紫杉醇脂质体、长春瑞滨和吉西他滨这三类药物在乳腺肿瘤治疗中使用越来越普遍。它们在用法、相互作用、不良反应等方面各有讲究。这篇文章将系统介绍7个关键用药细节，帮助你安全高效地使用这类药品。\u003C/p>\n  \u003C/div>\n  \n  \u003C!-- 紫杉醇脂质体：用药关键细节 -->\n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg image-bg01\">\u003C/div>\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01️⃣ 紫杉醇脂质体的剂型特点与优势\u003C/h2>\n    \u003Cp>紫杉醇脂质体是一种将紫杉醇包裹在脂质体中的注射剂型（IV），主要用于静脉输注。脂质体技术降低了紫杉醇对普通组织的毒性，提高了药物在肿瘤区的聚集率，使药物副作用更容易被患者耐受。与常规紫杉醇相比，脂质体制剂对过敏反应的发生率更低，使用时无需苯海拉明和糖皮质激素的预处理。\u003C/p>\n    \u003Cp>正确做法：仅可静脉给药，输注前务必检查药品包装完整性及有效期。不建议自行调整剂量或给药速度，应遵循医生建议。\u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg image-bg02\">\u003C/div>\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02️⃣ 紫杉醇脂质体的用药时间和方法\u003C/h2>\n    \u003Cp>紫杉醇脂质体应每21-28天一个周期使用。每次输注时间不应过快，通常建议在1小时以上。具体的剂量与输注速度需由专业医师根据体重和耐受情况制定。\u003C/p>\n    \u003Cp>需要注意：输注期间若出现不适，如面部潮红、心跳加快，应立即告知医护人员。\u003C/p>\n    \u003Cp>临床应用案例：一位57公斤女性患者按标准方案输注紫杉醇脂质体，未出现严重不良反应，但有短暂的皮肤痒感，经减慢输液速度后缓解。\u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg image-bg03\">\u003C/div>\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03️⃣ 紫杉醇脂质体的药物相互作用\u003C/h2>\n    \u003Cp>紫杉醇脂质体与酮类抗真菌药（如伊曲康唑）、某些抗病毒药物（如利托那韦）有明显相互作用，可能增强毒性或抑制代谢。与特定抗心律失常药、某些降压药联合时也需注意可能的药效变化。\u003C/p>\n    \u003Cp>正确做法：使用紫杉醇脂质体前，应主动告知医生所有正在用的药品，避免因药物相互作用发生预期外的副作用。\u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg image-bg04\">\u003C/div>\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04️⃣ 用药期间特殊人群的注意事项\u003C/h2>\n    \u003Cp>紫杉醇脂质体在肝肾功能不全患者和老年人使用时，需根据个体情况调整剂量。孕妇及哺乳期妇女禁用。儿童使用暂未有明确指导，仅供成人使用。\u003C/p>\n    \u003Cp>特别提醒：如长期服用后出现皮肤黄染、尿色加深、极度乏力，应尽快与医生联系。\u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg image-bg05\">\u003C/div>\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05️⃣ 紫杉醇脂质体的不良反应与处理办法\u003C/h2>\n    \u003Cp>常见不良反应包括白细胞减少、周围神经麻木、脱发和皮肤瘙痒。严重时可能出现过敏反应和心脏毒性。数据显示，脂质体紫杉醇过敏反应明显少于常规制剂（Rowinsky EK et al., 1999）。\u003C/p>\n    \u003Cp>正确做法：出现发热、皮疹、严重乏力等不适，应立即停药并就医。如果输注过程中出现呼吸困难或血压下降，需紧急处理。\u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg image-bg06\">\u003C/div>\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06️⃣ 紫杉醇脂质体的储存与过期处理\u003C/h2>\n    \u003Cp>此类药品需要在2-8°C冷藏储存，避免阳光直射。药品开瓶后应尽快用完，剩余的药液不可再次使用。过期或变色药品必须丢弃，不能用于治疗。\u003C/p>\n    \u003Cp>正确做法：家用冰箱储存应避免放在冷冻室，使用前检查药品标签及外观。\u003C/p>\n  \u003C/section>\n  \n  \u003C!-- 长春瑞滨：用药实用细节 -->\n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg image-bg07\">\u003C/div>\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07️⃣ 长春瑞滨的作用机制简述\u003C/h2>\n    \u003Cp>长春瑞滨（Vinorelbine）是一种微管蛋白抑制剂。其通过干扰细胞分裂过程，阻止肿瘤细胞增殖。作为静脉注射剂，用于乳腺肿瘤相关治疗。\u003C/p>\n    \u003Cp>正确做法：通用推荐为每周一次静脉输注，实际剂量和周期由医生严格管理。\u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg image-bg08\">\u003C/div>\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08️⃣ 长春瑞滨的服用方法与使用技巧\u003C/h2>\n    \u003Cp>仅支持静脉注射，不可口服，不可皮下注射。若药瓶出现混浊或沉淀，应弃用。\u003C/p>\n    \u003Cp>需要注意：用药当天避免高脂肪饮食，饮水可缓解口腔黏膜不适。\u003C/p>\n    \u003Cp>临床案例：一位中年女性在联合用药时按周期静脉输注长春瑞滨，出现口腔黏膜稍微溃疡，用药间期加强含漱后明显改善。\u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg image-bg09\">\u003C/div>\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09️⃣ 长春瑞滨的不良反应与防控\u003C/h2>\n    \u003Cp>最常见副作用为白细胞减少和口腔黏膜炎。部分患者可能出现肌肉疼痛、便秘。数据显示，约20-35%患者在治疗期间出现中度骨髓抑制（Arbuck SG et al., 1992）。\u003C/p>\n    \u003Cp>正确做法：用药期间及时监测血常规，出现持续发热、感染迹象即刻就医。\u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg image-bg10\">\u003C/div>\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10️⃣ 长春瑞滨的药物相互作用\u003C/h2>\n    \u003Cp>与其他肿瘤化疗药物（如顺铂、紫杉醇）联合时，需密切监控骨髓抑制。与抗真菌药和某些抗生素同时用药可能影响其代谢或毒性。\u003C/p>\n    \u003Cp>需要注意：切不可与含葡萄柚汁同时服用，会影响药物清除速度。\u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg image-bg11\">\u003C/div>\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">11️⃣ 长春瑞滨的储存与处理\u003C/h2>\n    \u003Cp>应储存在室温（15-25°C）下，避光密封。开瓶后应迅速使用，剩余药液需规范处理。过期药品勿用。\u003C/p>\n  \u003C/section>\n  \n  \u003C!-- 吉西他滨：用药实用细节 -->\n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg image-bg12\">\u003C/div>\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">12️⃣ 吉西他滨的作用和适应范围\u003C/h2>\n    \u003Cp>吉西他滨（Gemcitabine）是一类核苷类似物，通过干扰DNA合成阻止肿瘤细胞繁殖。常用于联合紫杉醇、长春瑞滨在乳腺相关治疗方案中。\u003C/p>\n    \u003Cp>正确做法：吉西他滨能通过静脉滴注，每周一次或每两周一次，剂量需严格按照体重和方案调整。\u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg image-bg13\">\u003C/div>\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">13️⃣ 吉西他滨的用法和用药时间\u003C/h2>\n    \u003Cp>应由专业人员静脉输注。每次输液需持续30分钟以上，不能与其他药品混合同瓶。\u003C/p>\n    \u003Cp>需要注意：输注当日应避免剧烈运动，更要补充足量水分。\u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg image-bg14\">\u003C/div>\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">14️⃣ 吉西他滨的药物相互作用\u003C/h2>\n    \u003Cp>与顺铂或紫杉醇合用时，可能增加骨髓抑制风险。与某些非甾体抗炎药（NSAIDs）同时用药需警惕肾毒性增加。\u003C/p>\n    \u003Cp>正确做法：服用吉西他滨期间需每周及时监测血细胞及肾功能。\u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg image-bg15\">\u003C/div>\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">15️⃣ 吉西他滨的不良反应和处理方法\u003C/h2>\n    \u003Cp>常见副作用包括白细胞减少、轻度肝酶升高、皮疹和轻微过敏反应。部分患者会有轻度发热。\u003C/p>\n    \u003Cp>需要注意：出现恶心、呕吐或皮疹时，可酌情减量或暂缓，需与主治医生紧密沟通。\u003C/p>\n    \u003Cp>临床案例：在吉西他滨+紫杉醇联合用药方案中，一名患者出现暂时性白细胞下降，经调整周期和加强监测后恢复正常。\u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg image-bg16\">\u003C/div>\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">16️⃣ 吉西他滨的储存和过量危害\u003C/h2>\n    \u003Cp>吉西他滨干粉需在室温（15-25°C）避光、干燥保存，配制后24小时内用完。过量使用可导致严重骨髓抑制和肝肾损伤。\u003C/p>\n    \u003Cp>正确做法：如误用或超量，务必立即就医。\u003C/p>\n  \u003C/section>\n  \n  \u003C!-- 漏服、剂量调整与安全问题 -->\n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg image-bg17\">\u003C/div>\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">17️⃣ 化疗药物漏服和过量后的补救措施\u003C/h2>\n    \u003Cp>如因特殊情况漏服静脉化疗，应及时与主治医生联系，不可自行补药。过量输注后需立即就医，由专业医师监控血象及器官功能。\u003C/p>\n    \u003Cp>特别提醒：所有化疗药物必须严格按照医嘱、周期和剂量进行，杜绝自行增减剂量。\u003C/p>\n  \u003C/section>\n  \n  \u003C!-- 结尾：用药指南总结 -->\n  \u003Csection class=\"material-section-end\">\n    \u003Cdiv class=\"material-bg image-bg18\">\u003C/div>\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🔑 用药指南小结与安全提醒\u003C/h2>\n    \u003Cp>其实，无论是紫杉醇脂质体、长春瑞滨还是吉西他滨，都需要严格执行静脉给药、周期管理、监测不良反应和合理储存。最重要的是：\u003Cstrong>一定要主动告知医生当前所有药物情况，并严格遵守用药周期与剂量\u003C/strong>。出现发热、感染或皮肤、肝肾异常，要及时就医。\u003C/p>\n    \u003Cp>科学、规范地用药，不仅能提升治疗效果，更能大幅降低风险。安全优先，正确执行，每一步都至关重要。\u003C/p>\n    \u003Cp>建议将关键用药信息告知家人，并保存药品说明书和用药记录以供参考。\u003C/p>\n    \u003Cp class=\"material-emoji\">💉🧪📋\u003C/p>\n  \u003C/section>\n\n  \u003C!-- 参考文献与数据出处 -->\n  \u003Csection class=\"material-section-ref\">\n    \u003Cdiv class=\"material-bg image-bg19\">\u003C/div>\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">📚 参考文献\u003C/h2>\n    \u003Col class=\"material-ref-list\">\n      \u003Cli>Rowinsky, E. K., Cazenave, R. H., & Donehower, R. C. (1999). Paclitaxel (Taxol). New England Journal of Medicine, 332(15), 1004–1014.\u003C/li>\n      \u003Cli>Arbuck, S. G., Blaylock, B. A., & Goodwin, J. W. (1992). Vinorelbine: Mechanism of action and clinical uses. Cancer Treatment Reviews, 18(3), 187–198.\u003C/li>\n      \u003Cli>Adams, D., & El-Rayes, B. F. (2017). Gemcitabine: preclinical and clinical perspectives. Cancer Chemotherapy and Pharmacology, 79(3), 465–474.\u003C/li>\n    \u003C/ol>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.material-wrapper {\n  font-family: \"Helvetica Neue\", Arial, \"PingFang SC\", \"Microsoft Yahei\", sans-serif;\n  background-color: #FCFCFF;\n  color: #32343a;\n  max-width: 900px;\n  margin: 30px auto;\n  box-shadow: 0 4px 18px rgba(70,110,150,0.07);\n  border-radius: 14px;\n  padding: 28px 40px 38px 40px;\n  position: relative;\n}\n.material-title {\n  font-size: 2.2em;\n  color: #45295f;\n  text-align: center;\n  border-bottom: 1px solid #e5e6ec;\n  padding-bottom: 18px;\n  margin-top: 0;\n  margin-bottom: 24px;\n  letter-spacing: 2px;\n}\n.material-intro {\n  font-size: 1.07em;\n  background: linear-gradient(90deg,#eaf0fa 0%, #f6f3ff 100%);\n  border-radius: 8px;\n  padding: 22px 30px 18px 30px;\n  margin-bottom: 38px;\n}\n.material-section {\n  margin-top: 24px;\n  margin-bottom: 18px;\n  position: relative;\n  border-radius: 12px;\n  background: #f7f8fb;\n  box-shadow: 0 2px 9px rgba(80,125,180,0.04);\n  padding: 34px 34px 28px 34px;\n  overflow: hidden;\n}\n.material-section-end {\n  margin-top: 34px;\n  margin-bottom: 10px;\n  position: relative;\n  border-radius: 12px;\n  background: linear-gradient(93deg,#f2f7fa 50%, #ede5fd 100%);\n  box-shadow: 0 2px 10px rgba(100,90,140,0.06);\n  padding: 38px 36px 32px 36px;\n}\n.material-section-ref {\n  margin-top: 26px;\n  margin-bottom: 6px;\n  position: relative;\n  border-radius: 12px;\n  background: linear-gradient(90deg,#fcf8fa 0%, #e8f6ec 100%);\n  box-shadow: 0 2px 5px rgba(90,135,150,0.04);\n  padding: 26px 32px 20px 32px;\n}\n.material-subtitle {\n  font-size: 1.34em;\n  color: #5e368e;\n  background: linear-gradient(90deg,rgba(126,183,230,0.22) 0%,rgba(195,159,222,0.24) 100%);\n  border-radius: 8px;\n  padding: 16px 18px 10px 18px;\n  margin-bottom: 16px;\n  box-shadow: 0 2px 7px rgba(85,95,130,.06);\n  letter-spacing: 1px;\n}\n.material-bg {\n  position: absolute;\n  top: 11px;\n  left: -28px;\n  right: -18px;\n  height: 60px;\n  border-radius: 10px 10px 0 0;\n  opacity: .19;\n  z-index: 0;\n}\n.image-bg01 { background: linear-gradient(90deg, #d6e6fa 40%, #efd5fa 100%); }\n.image-bg02 { background: linear-gradient(90deg, #e9d5ff 50%, #f8f3fa 100%); }\n.image-bg03 { background: linear-gradient(90deg, #fdebd3 40%, #f6f3fa 100%); }\n.image-bg04 { background: linear-gradient(90deg, #e7ede6 40%, #ffefef 100%); }\n.image-bg05 { background: linear-gradient(90deg, #f9e3ec 40%, #ecf7fa 100%); }\n.image-bg06 { background: linear-gradient(90deg, #e4f7fd 40%, #efefef 100%); }\n.image-bg07 { background: linear-gradient(90deg, #f2e7fb 40%, #e2f6fe 100%); }\n.image-bg08 { background: linear-gradient(90deg, #f8efd5 40%, #e7edfa 100%); }\n.image-bg09 { background: linear-gradient(90deg, #e9f2fe 40%, #f8faf4 100%); }\n.image-bg10 { background: linear-gradient(90deg, #e6f2fa 55%, #f5e5fe 100%); }\n.image-bg11 { background: linear-gradient(90deg, #faf1e6 35%, #f3f8fa 100%); }\n.image-bg12 { background: linear-gradient(90deg, #e7fafa 35%, #f4edfa 100%); }\n.image-bg13 { background: linear-gradient(90deg, #f7e8ff 45%, #eaf3fa 100%); }\n.image-bg14 { background: linear-gradient(90deg, #e2f1ee 45%, #faf6ed 100%); }\n.image-bg15 { background: linear-gradient(90deg, #fce2d6 45%, #edf4fd 100%); }\n.image-bg16 { background: linear-gradient(90deg, #eff7f8 45%, #fde6f3 100%); }\n.image-bg17 { background: linear-gradient(90deg, #e3eefe 45%, #fcf3ea 100%);}\n.image-bg18 { background: linear-gradient(90deg, #efeafd 60%, #e8f6ed 100%);}\n.image-bg19 { background: linear-gradient(90deg, #f6ebfc 60%, #e0f8f0 100%);}\n.material-emoji {\n  font-size: 1.74em;\n  text-align: center;\n  letter-spacing: 1.5px;\n  margin-top: 16px;\n}\n.material-ref-list li {\n  margin-bottom: 9px;\n  font-size: 1.07em;\n  color: #48415d;\n  padding-left: 2px;\n}\n@media (max-width: 800px) {\n  .material-wrapper {\n    padding: 14px;\n    margin: 10px auto;\n  }\n  .material-section, .material-section-end, .material-section-ref {\n    padding: 14px 10px 9px 10px;\n  }\n  .material-intro {\n    padding: 11px 7px 10px 7px;\n  }\n  .material-title {\n    font-size: 1.4em;\n    padding-bottom: 10px;\n    margin-top: 8px;\n    margin-bottom: 11px;\n  }\n  .material-subtitle {\n    font-size: 1.06em;\n    padding: 10px 10px 6px 10px;\n  }\n}\n\u003C/style>\n\n","\u003C!-- 乳腺癌治疗新选择：深入了解紫杉醇脂质体等药物 | 正确用药实用指南 -->\n\u003Cdiv class=\"material-wrapper\">\n  \u003Ch1 id=\"material_title\" ",566,"2025-08-21 14:32:40","乳腺癌, 紫杉醇脂质体, 长春瑞滨, 吉西他滨, 化疗药物, 用药指南, 不良反应, 药物相互作用","了解最新的乳腺癌治疗方案，包括紫杉醇脂质体、长春瑞滨和吉西他滨等化疗药物，帮助患者安全高效用药，提升治疗效果。","2025-08-21 16:26:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]